Related Experiment Video
Updated: Jul 19, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Vaccine assembly from surface proteins of Staphylococcus aureus
Yukiko K Stranger-Jones1, Taeok Bae, Olaf Schneewind
1Department of Microbiology, University of Chicago, 920 East 58th Street, Chicago, IL 60637, USA.
Developing a Staphylococcus aureus vaccine is crucial due to rising antibiotic resistance. Targeting four surface proteins (IsdA, IsdB, SdrD, SdrE) in mice induced protective immunity against dangerous S. aureus infections.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Staphylococcus aureus is a leading cause of hospital-acquired infections.
- The rise of antibiotic-resistant strains poses a significant public health risk.
- Developing effective vaccines is essential to combat these infections.
Purpose of the Study:
- To evaluate cell wall-anchored surface proteins of S. aureus as vaccine antigens.
- To assess the protective efficacy of these antigens in a murine model of infection.
- To develop a broadly protective vaccine against S. aureus.
Main Methods:
- Tested four S. aureus cell wall-anchored surface proteins (IsdA, IsdB, SdrD, SdrE) as antigens.
- Utilized a murine model of abscess formation to assess protective immunity.
- Measured opsonophagocytic antibody induction post-immunization.
Main Results:
- Immunization with the four antigens generated significant protective immunity in mice.
- Protective immunity correlated with the induction of opsonophagocytic antibodies.
- A combined vaccine of the four proteins provided high protection against invasive S. aureus disease.
Conclusions:
- Cell wall-anchored surface proteins of S. aureus are promising vaccine candidates.
- A multi-antigen vaccine approach can confer broad protection against S. aureus.
- This strategy holds potential for a broadly protective vaccine against S. aureus infections.
More Related Videos
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Related Concept Videos
Staphylococcal Skin Infections
Vaccine Production
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Formation of Lipopolysaccharides
Vaccines
Vaccinations